ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Circ_0072088 knockdown contributes to cisplatin sensitivity and inhibits tumor progression by miR-944/LASP1 axis in non-small cell lung cancer

Zhang, Lei; Wu, Yuanzhou; Hou, Chunyang; Li, Fangzhi*南方医科大学; 中国医科大学; 1
Journal of Gene Medicine2022-5DOI: 10.1002/jgm.3414
4被引7阅读
引用收藏
分享

摘要

Background Non-small cell lung cancer (NSCLC) is an aggressive tumor that accounts for a large proportion of cancer-related deaths. Cisplatin (CDDP) has been utilized to treat NSCLC. However, the efficacy of CDDP is usually restrained owing to the development of drug resistance. This study aims to reveal the molecular mechanism of the resistance of NSCLC cells to CDDP. Methods The expression levels of circRNA_0072088 (circ_0072088), microRNA-944 (miR-944), and LIM and SH3 protein 1 (LASP1) were measured by quantitative real-time PCR (qRT-PCR) in CDDP-resistant NSCLC tissues and cells. Protein expression was determined by Western blotting in CDDP-resistant NSCLC tissues and cells. The functional effects of circ_0072088, miR-944, and LASP1 on CDDP sensitivity and NSCLC progression were revealed by Cell Counting Kit-8 (CCK-8), flow cytometry, cell colony formation, wound healing, and transwell invasion assays. The binding relationship between miR-944 and circ_0072088 or LASP1 was identified by a dual-luciferase reporter and RNA immunoprecipitation assay. The effects of circ_0072088 knockdown on tumor growth in vivo were analyzed by an in vivo tumor formation assay. Results Circ_0072088 and LASP1 expression were significantly upregulated, while miR-944 expression was downregulated in CDDP-resistant NSCLC tissues and cells as compared with control groups. Circ_0072088 expression was significantly associated with tumor-node-metastasis stage and tumor size. Functionally, circ_0072088 knockdown improved CDDP sensitivity and repressed NSCLC cell malignancy, whereas miR-944 inhibitor hindered these effects. Mechanistically, circ_0072088 functioned as a sponge for miR-944 and miR-944 targeted LASP1. Circ_0072088 knockdown improved the sensitivity of tumor to CDDP in vivo. Conclusion Circ_0072088 silencing improved CDDP sensitivity and inhibited NSCLC progression by downregulating LASP1 expression through sponging miR-944. These data provide novel insight into the resistance of NSCLC to CDDP.

学科与关键词

关键词
CDDPcirc_0072088LASP1miR-944NSCLC
相关
加载中…
  • Knockdown of LINC00511 decreased cisplatin resistance in non-small cell lung cancer by elevating miR-625 level to suppress the expression of leucine rich repeat containing eight volume-regulated anion channel subunit E
    Liu, Benkun; Zhou, Fucheng; Liu, He; Wang, Yanbo; Wang, Junfeng; Ren, Fenghai; Xu, Shidong*Human and Experimental Toxicology, 2022, 41: 09603271221089000.被引 7
  • circRNA_103615 contributes to tumor progression and cisplatin resistance in NSCLC by regulating ABCB1
    Liang, Hongguang; Lin, Zelong; Lin, Huiwen; Zhao, Li; Huang, Weihua*Experimental and Therapeutic Medicine, 2021, 22(3): 934.被引 6
  • A novel circ_MACF1/miR-942-5p/TGFBR2 axis regulates the functional behaviors and drug sensitivity in gefitinib-resistant non-small cell lung cancer cells
    Fan, Daping; Yang, Yue; Zhang, Wei*BMC Pulmonary Medicine, 2022, 22(1): 27.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Gene Medicine
发表日期
2022-05
卷期
第 24 卷, 第 5 期
页码
e3414
DOI
10.1002/jgm.3414
语言
ENGLISH
期刊等级
4区
成果收录
SCIE

作者

  • Z

    Zhang, Lei (第一作者)

    shanghai univ tradit chinese med

  • W

    Wu, Yuanzhou

    southern med univ

查看全部 4 位作者收起作者
  • H

    Hou, Chunyang

  • L

    Li, Fangzhi (通讯)

    1 · china med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417